ArticleComputational and structural biotechnology journal2024
ALOA, a pipeline for preliminary analysis of spatial profiling imaging data.
Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Proteomic analyses of human islets reveal potential markers of β cell dysfunction during prediabetes.JCI insight · 2026Article
- PatternExtract: A Facile, Scalable Pipeline for Point Pattern Generation from Spatial Imaging Data.Computational and structural biotechnology journal · 2026Article
- Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the last decade, it has been recognized that tumors do not exist in isolation but interact with surrounding cells, blood vessels, immune cells, and extracellular matrix components. This understanding has shifted the focus from tumor cells alone to the broader context in which they exist, known as tumor microenvironment (TME). The TME is highly heterogeneous, consisting of various cell types, mainly cancer cells, immune cells, and stromal cells. The interactions among different cell types in the TME significantly influence tumor progression, immune evasion, and response to therapy. Spatial profiling helps to map these interactions, providing insights into how cells communicate and influence each other, analyzing them in their spatial context. However, there is a lack of tools capable of efficiently analyzing this type of data. As a matter of fact, the most commonly used tool, phenoptr, is time consuming, lacks automation, and is often not user friendly. In this scenario, ALOA (Analysis spatiaL prOfiling imAging), represents a tool that, starting from inForm™ data, provides a complete and accurate analysis along with accompanying graphs and statistical analysis. Of note, ALOA is specifically designed to handle spatial coordinates and image-based data derived from multiplexed immunohistochemistry (IHC) and immunofluorescence (IF). Therefore, it is not suited to work with single cell transcriptomics or non-spatial single cell transcriptomics data, which require specific tools for handling high-dimensional gene expression information. We integrated Phenoimager multiplexed tissue imaging with the ALOA modeling algorithm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.